30 Day Trial
BARE BONES logo

BARE BONES content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Product / Company Performance

X-BOLT Hip Fixation Shows 0.8% Reoperation Rate in Study -

Preliminary study results indicate that X-BOLT Orthopaedics' X-BOLT expanding bolt device for hip fracture repair demonstrated a cut-out rate of 0.8% in a population of 476 patients, and performed as well as a sliding hip screw (SHS) in measures such as quality of life, mortality, residential status, revision and radiographic measures. World Hip Trauma Evaluation 4 (WHITE4) is the largest ever multi-center randomized controlled trial comparing extracapsular hip fracture fixation devices. Recruitment of over 1,000 patients at 10 centers in the U.K. began in June 2016, with patients receiving either an SHS or X-BOLT. Follow-up occurred at baseline, four weeks, four months and one year. X-BOLT is approved under the CE Mark and received FDA 510(k) market clearance. It can be manufactured in stainless steel or titanium, and is adaptable for other areas of osteoporotic fixation, such as the spine. (X-BOLT Orthopaedics, 9/13/19)